Showing results (91-100 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|January 9, 2014
Clinical trials in hepatocellular carcinoma: an updateYing-Chun Shen, Zhong-Zhe Lin, Chih-Hung Hsu, et al.
Liver Cancer|July 11, 2020
Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular CarcinomaHaijing Deng, Anna Kan, Ning Lyu, et al.
Liver Cancer|July 11, 2020
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus StatementsMasatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, et al.
Liver Cancer|August 20, 2025
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational StudyYoon Jun Kim, Philippe Merle, Richard S Finn, et al.
Liver Cancer|June 26, 2025
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-BevacizumabBernardo Stefanini, Fabio Piscaglia, Fabio Marra, et al.
Liver Cancer|June 26, 2025
The Risk of Decompensation in Steatotic Liver Disease-Related Hepatocellular Carcinoma: A Comparison with Viral-Controlled CasesYuki Matsushita, Tatsuya Minami, Yoshikuni Kawaguchi, et al.
Liver Cancer|August 20, 2025
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus BevacizumabJaekyung Cheon, Baek-Yeol Ryoo, Hong Jae Chon, et al.
Liver Cancer|June 23, 2025
Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular CarcinomaXinyu Bi, Yinying Lu, Bo Chen, et al.
Liver Cancer|June 23, 2025
Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular CarcinomaKeisuke Koroki, Sadahisa Ogasawara, Ryo Izai, et al.
Liver Cancer|May 29, 2025
Matching-Adjusted Indirect Comparison of Arterial FOLFOX and Atezolizumab-Bevacizumab in Unresectable Hepatocellular CarcinomaYi-Min Zhang, Xin-Tong Wu, Jun-Zhe Yi, et al.
Pageof 55